Home
Search

Amicus Briefs

BIO submits amicus briefs on a variety of topics because of the strong interest and relevance to the biotechnology industry.

Featured Amicus Briefs
BIO Files Amicus Brief in Delaware Supreme Court…
BIO filed an amicus brief in the Supreme Court of the State of Delaware, urging the Court to exclude Plaintiffs’ expert opinion, thereby ensuring that Delaware’s standard for the admission of such evidence remains consistent with the federal …
Learn more
BIO Files Amicus Briefs Supporting the Lawfulness…
On February 10, 2025, BIO filed an amicus brief in the U.S. District Court for the District of Columbia, supporting the lawfulness of plaintiff Eli Lilly's proposed 340B rebate model. The 340B Drug Pricing Program ("340B"), through which Medicaid…
Learn more
BIO Files Amicus Brief on FDA Orange Book Listing…
BIO filed an amicus brief in the U.S. Court of Appeals for the Federal Circuit urging rehearing of a case involving whether certain Teva Pharmaceuticals patents had been properly listed in FDA’s Orange Book (Approved Drug Products with Therapeutic…
Learn more
All Amicus Briefs
  • Show All
Search
Results
BIO Files Amicus Brief on Case Addressing Unfairness or Imbalance in Post-Grant Proceedings at PTO (U.S. Court of Appeals for the Federal Circuit)
April 9, 2018
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
BIO files Amicus Brief in Patent Case Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc. (U.S. Court of Appeals for the Federal Circuit)
August 14, 2017
BIO submitted an amicus brief in the U.S. Court of Appeals for the Federal Circuit, supporting Acorda Therapeutics and reversal. 
BIO Files Amicus Brief Supporting Rehearing of Case Addressing Patent Rights and America Invents Act (AIA) at the U.S. Court of Appeals for the Federal Circuit
July 14, 2017
BIO files Amicus Brief supporting rehearing en banc in Helsinn v. Teva Phamaceuticals (US Court of Appeals for the Federal Circuit)
BIO Submits Amicus Brief in Sandoz Inc. v. Amgen Manufacutring Inc. and Amgen Manufacturing Ltd v. Sandoz Inc. (U.S. Supreme Court)
March 17, 2017
BIO Submits Brief of Amicus Curiae in Sandoz Inc. v. Amgen Inc. v. Sandoz Inc. (Supreme Court of the United States)  
BIO and AUTM Submit Amicus Brief in Patent Venue Case, TC Heartland LLC v. Kraft Food Group Brands LLC (U.S. Supreme Court)
March 8, 2017
BIO and AUTM Submit Brief of Amicus Curiae in TC Heartland LLC v. Kraft Food Group Brands LLC (Supreme Court of the United States)
BIO and Croplife International Submit Amicus Brief in Impression Products Inc. v. Lexmark International Inc. (U.S. Supreme Court)
February 23, 2017
BIO and Croplife International Submit Brief of Amicus Curiae in Impression Products Inc. v. Lexmark International Inc. (Supreme Court of the United States)
BIO Submits Amicus Brief in Wi-Fi One, LLC v. Broadcom Corporation (U.S. Court of Appeals for the Federal Circuit)
February 23, 2017
BIO Submits Brief of Amicus Curiae in Wi-Fi One, LLC v. Broadcom Corporation (U.S. Court of Appeals for the Federal Circuit)
BIO and PhRMA Submit Amicus Brief In Re: Verinata Health Inc., Illumina, Inc. (U.S. Court of Appeals for the Federal Circuit)
February 9, 2017
BIO and PhRMA Submit Brief of Amicus Curiae In Re: Verinata Health Inc., Illumina, Inc. 
BIO submits amicus brief In Re Aqua Products, Inc. (U.S. Court of Appeals for the Federal Circuit)
October 25, 2016
The Biotechnology Innovation Organization submitted a brief of amicus curiae supporting the appellant in the case In Re: Aqua Product, Inc. in the United States Court of Appeals for the Federal Circuit
BIO Amicus Brief in The Medicines Company v. Hospira, Inc. (U.S. Court of Appeals)
March 3, 2016
Modern pharmaceutical and biotechnology products typically require lengthy, costly, and resource-intensive development periods before they reach the marketplace. BIO members devote many years and millions of dollars in direct …